Article
First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.
World journal of gastroenterology - 28 Dec 2015
Saito Yoshimasa, Serizawa Hiroshi, Kato Yukako, Nakano Masaru, Nakamura Masahiko, Saito Hidetsugu, Suzuki Hidekazu, Kanai Takanori
Abstract excerpt
AIM: To evaluate the effect of first line esomeprazole (EPZ)-based triple therapy on Helicobacter pylori (H. pylori) eradication. METHODS: A total of 80 Japanese patients with gastritis who were diagnosed as positive for H. pylori infection by endoscopic biopsy-based or (13)C-urea breath tests were included in this study. The average age of the patients was 57.2 years (male/female, 42/38). These patients were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
